UDCA tied to reduction in risk of stillbirth, preterm birth in women with ICP
29 Jun 2021
byAudrey Abella
Among women with intrahepatic cholestasis of pregnancy (ICP), ursodeoxycholic acid (UDCA) treatment was associated with a reduction in the risk of composite adverse perinatal outcomes of stillbirth and preterm birth (PTB), a meta-analysis suggests.
UDCA tied to reduction in risk of stillbirth, preterm birth in women with ICP
29 Jun 2021